**SEC 2026 Examination Priorities Explicitly Target AI Claims: Regulated Firms Must Now Evidence Supervision**
The UK’s Securities and Exchange Commission (SEC) has recently announced its 2026 examination priorities, placing a significant emphasis on the claims vendors make about their artificial intelligence (AI) solutions. In regulated industries such as healthcare, insurance, and financial services – where organisations are held accountable for AI outcomes – this development is particularly important.
**What is happening?**
The SEC’s new priorities focus on ensuring that vendors accurately represent their AI capabilities and do not mislead buyers into purchasing ineffective or dangerous systems. This means that regulators will scrutinise AI-related claims made by vendors, including those related to data accuracy, security, and performance.
In regulated industries, organisations can no longer rely solely on vendor assurances; they must now evidence the supervision of these claims within their own governance processes.
**Why it demands action now**
Organisations exposed to this development face three critical risks: capability risk (does the AI technology do what was claimed?), governance risk (can the decision be defended when boards or regulators ask), and liability risk (what is the organisation accountable for when the AI errs?).
Capability risk is sharpened most by this development, as buyers must now verify vendors’ claims without relying solely on their word. In regulated sectors like healthcare, where a wrong answer can have devastating consequences, it is crucial that organisations ensure they are purchasing solutions that meet their specific needs.
The action: prudent organisations should take the following steps to address these risks:
1. Review vendor claims and assess them against their real operations, people, governance obligations, legal exposure, and regulatory expectations.
2. Develop internal processes for evaluating AI capabilities based on verifiable evidence and not solely on vendor information or marketing material.
3. Ensure that decision-making teams are equipped with the skills to understand AI limitations and make informed choices.
**How Straven helps**
Straven & Co is an independent AI validation firm that provides organisations with a third-party assessment of their proposed AI solutions against their real operations, people, governance obligations, legal exposure, and regulatory expectations. The company delivers a plain verdict – proceed, proceed with conditions, or do not – to protect clients from the cost of unexamined AI decisions.
Straven’s expertise lies in its ability to examine AI decisions before they are acted upon, providing organisations with an independent assessment that can be trusted. With no product to sell and nothing earned by recommending more, Straven & Co’s verdict is unbiased and reliable.
**Straven & Co examines AI decisions before they are acted on: stravenandco.com**
By addressing these risks proactively and seeking independent validation from firms like Straven & Co, organisations can ensure that their AI investments align with their business goals and regulatory requirements.